Bio-Rad Laboratories, Inc. BIO
Set alert
366.16 USD 0.00 0.00%
At close
373.78 +7.62 +2.08%
Pre-market · Nov 3, 9:04 AM ET
361.27 Day range 377.90
236.73 52-week range 396.23
- YTD
- +20.85%
- 1 year
- +14.59%
- Open
- 374.79
- Prev close
- 366.16
- Mkt cap
- 9.79B
- Vol
- 211.83K
- Avg vol
- 254.03K
- EPS
- 7.89
- P/E
- 46.41
- Div yield
- 0.00%
More statistics
- Low
- 361.27
- High
- 377.90
- Forward P/E
- 37.57
- Beta
- 1.06
- Short ratio
- 4.17
- Inst. own
- 91.74%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 374.80
- 200-d avg
- 313.41
- 1y target
- 335.00
5D chart
Signals (119)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:55 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:40 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:00 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:55 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:20 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:00 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 3 days ago |
Newest 20 of 119.
Financial health
Altman Z-Score
3.62 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 3
- Return on Equity 2
- Return on Assets 3
- Debt / Equity 3
- P/E 2
- P/B 4
Valuation
P/E 10.9×
FY 2016 5y median -3.5× FY 2025
P/S 3.2×
FY 2016 5y median 3.6× FY 2025
P/B 1.1×
FY 2016 5y median 1.3× FY 2025
P/FCF 22.1×
FY 2016 5y median 42.1× FY 2025
EV/EBITDA 7.7×
FY 2016 5y median -3.0× FY 2025
EV/Sales 3.6×
FY 2016 5y median 4.0× FY 2025
FCF Yield 4.5%
FY 2016 5y median 2.4% FY 2025
Profitability
Gross Margin 52.0%
FY 2016 5y median 53.7% FY 2025
Operating Margin 10.5%
FY 2016 5y median 12.6% FY 2025
Net Margin 29.4%
FY 2016 5y median -23.9% FY 2025
ROE 10.2%
FY 2016 5y median -7.3% FY 2025
ROIC 2.0%
FY 2016 5y median 2.3% FY 2025
ROA 7.2%
FY 2016 5y median -5.2% FY 2025
Growth (YoY)
Revenue 0.7%
FY 2016 FY 2025
Operating Income 0.6%
FY 2016 FY 2025
EPS (diluted) 142.6%
FY 2016 FY 2025
Free Cash Flow 40.7%
FY 2016 FY 2025
Financial Health
Current Ratio 5.6×
FY 2016 5y median 5.6× FY 2025
Quick Ratio 4.2×
FY 2016 5y median 4.3× FY 2025
Debt / Equity 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.8×
FY 2016 5y median -0.2× FY 2025
Interest Coverage 5.5×
FY 2016 5y median 6.8× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
